Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation

Therapeutic Advances in Respiratory Disease

Volumn 8, Issue 1, 2014, Pages 3-12

  Haidar, Yarah M ^a   Rahn, Douglas A ^a   Nath, Sameer ^b   Song, William ^b   Bazhenova, Lyudmila ^b   Makani, Samir ^b   Fuster, Mark M ^b   Sandhu, Ajay P ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

lung cancer; non small cell lung cancer; pathologic diagnosis; radiotherapy; stereotactic body radiotherapy

Indexed keywords

LUNG CANCER; NON-SMALL CELL LUNG CANCER; PATHOLOGIC DIAGNOSIS; RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONIC COUGH; CHRONIC TOXICITY; CONTROLLED STUDY; COUGHING; DYSPNEA; ESOPHAGITIS; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PLEURA EFFUSION; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; VERY ELDERLY;

EID: 84893085511     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465813512545     Document Type: Article

References (47)

1. Aberle D. Adams A. Berg C. Black W. Clapp J. Fagerstrom R. (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395–409.
2. Ahmad E. Sandhu A. Fuster M. Messer K. Pu M. Nobiensky P. (2011) Hypofractionated radiotherapy as definitive treatment of stage I non-small cell lung cancer in older patients. Am J Clin Oncol 34: 254–258.
3. Albert R. Russell J. (2009) Evaluation of the solitary pulmonary nodule. Am Fam Physician 80: 827–831.
4. Baumann P. Nyman J. Hoyer M. Wennberg B. Gagliardi G. Lax I. (2009) Outcome in a prospective phase II trial of medically inoperable stage i non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27: 3290–3296.
5. Bradley J. El Naqa I. Drzymala R. Trovo M. Jones G. Denning M. (2010) Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. Int J Radiat Oncol Biol Phys 77: 1146–1150.
6. Cerfolio R. Bryant A. (2009) Survival of patients with true pathologic stage i non-small cell lung cancer. Ann Thorac Surg 88: 917–922; discussion 922-923.
7. Chi A. Liao Z. Nguyen N. Xu J. Stea B. Komaki R. (2010) Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 94: 1–11.
8. Colice G. Shafazand S. Griffin J. Keenan R. Bolliger C. and American College of Chest Physicians (2007) Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132: 161S-177S.
9. Davies B. Ghosh S. Hopkinson D. Vaughan R. Rocco G. (2005) Solitary pulmonary nodules: pathological outcome of 150 consecutively resected lesions. Interact Cardiovasc Thorac Surg 4: 18–20.
10. Detterbeck F. Boffa D. Tanoue L. (2009) The new lung cancer staging system. Chest 136: 260–271.
11. Edey A. Hansell D. (2009) Incidentally detected small pulmonary nodules on CT. Clin Radiol 64: 872–884.
12. Gupta N. Maloof J. Gunel E. (1996) Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 37: 943–948.
13. Haasbeek C. Palma D. Visser O. Lagerwaard F. Slotman B. Senan S. (2012) Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol 23: 2743–2747.
14. Halperin E. Perez C. Brady L. (2007) Principles and Practice of Radiation Oncology. Philadelphia, PA: Lippincott Williams and Wilkins.
15. Hansen H. (2009a) Histopathology. In: Hansen H. (ed.), Lung Cancer Therapy Annual, 6th edition. New York: Informa Health Care.
16. Hansen H. (2009b) Introduction. In: Hansen H. (ed.), Lung Cancer Therapy Annual, 6th edition. New York: Informa Health Care.
17. Herder G. Kramer H. Hoekstra O. Smit E. Pruim J. Van Tinteren H. (2006) Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol 24: 1800–1806.
18. Herder G. Van Tinteren H. Golding R. Kostense P. Comans E. Smit E. (2005) Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 128: 2490–2496.
19. Inoue T. Shimizu S. Onimaru R. Takeda A. Onishi H. Nagata Y. (2009) Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. Int J Radiat Oncol Biol Phys 75: 683–687.
20. Jemal A. Bray F. Center M. Ferlay J. Ward E. Forman D. (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90.
21. Jemal A. Center M. Desantis C. Ward E. (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19: 1893–1907.
22. Jemal A. Siegel R. Xu J. Ward E. (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277–300.
23. Lagerwaard F. Haasbeek C. Smit E. Slotman B. Senan S. (2008) Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70: 685–692.
24. MacMahon H. Austin J. Gamsu G. Herold C. Jett J. Naidich D. (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 237: 395–400.
25. McGarry R. Song G. Des Rosiers P. Timmerman R. (2002) Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest 121: 1155–1158.
26. Meyers B. Haddad F. Siegel B. Zoole J. Battafarano R. Veeramachaneni N. (2006) Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. J Thorac Cardiovasc Surg 131: 822–829; discussion 822-829.
27. Murai T. Shibamoto Y. Baba F. Hashizume C. Mori Y. Ayakawa S. (2012) Progression of non-small-cell lung cancer during the interval before stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 82: 463–467.
28. Nath S. Sandhu A. Kim D. Bharne A. Nobiensky P. Lawson J. (2011) Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer. Radiother Oncol 99: 12–17.
29. Onishi H. Shirato H. Nagata Y. Hiraoka M. Fujino M. Gomi K. (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2: S94–100.
30. Ost D. Gould M. (2012) Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med 185: 363–372.
31. Palma D. Visser O. Lagerwaard F. Belderbos J. Slotman B. Senan S. (2010) Impact of introducing stereotactic lung radiotherapy for elderly patients with stage i non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 28: 5153–5159.
32. Pierce J. Messer K. White M. Cowling D. Thomas D. (2011) Prevalence of heavy smoking in California and the United States, 1965-2007. JAMA 305: 1106–1112.
33. Raz D. Zell J. Ou S. Gandara D. Anton-Culver H. Jablons D. (2007) Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 132: 193–199.
34. Sandhu A. Messer K. Fuster M. Ahmad E. Pu M. Bazhenova L. (2009) Definitive radiation therapy for stage I non-small-cell lung carcinoma: institutional experience with contemporary conformal planning. Clin Lung Cancer 10: 433–437.
35. Sato S. Koike T. Yamato Y. Yoshiya K. Motono N. Takeshige M. (2010) Diagnostic yield of preoperative computed tomography imaging and the importance of a clinical decision for lung cancer surgery. Gen Thorac Cardiovasc Surg 58: 461–466.
36. Sawada S. Yamashita M. Komori E. Nogami N. Oze I. Segawa Y. (2007) Evaluation of resected tumors that were not diagnosed histologically but were suspected of lung cancer preoperatively. J Thorac Oncol 2(Suppl. 4): S422.
37. Scott W. Howington J. Feigenberg S. Movsas B. Pisters K. and American College of Chest Physicians (2007) Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132: 234S-242S.
38. Siegelman S. Khouri N. Leo F. Fishman E. Braverman R. Zerhouni E. (1986) Solitary pulmonary nodules: CT assessment. Radiology 160: 307–312.
39. Smolle-Juettner F. Maier A. Lindenmann J. Matzi V. Neubock N. (2010) Resection in stage I/II non-small cell lung cancer. In: Heide J. Schimittel A. Kaiser D. Hinkelbein W. (eds), Controversies in the Treatment of Lung Cancer. Basel, Switzerland: Karger.
40. Stephans K. Djemil T. Reddy C. Gajdos S. Kolar M. Mason D. (2009) A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic Experience. J Thorac Oncol 4: 976–982.
41. Swensen S. Silverstein M. Ilstrup D. Schleck C. Edell E. (1997) The probability of malignancy in solitary pulmonary nodules. application to small radiologically indeterminate nodules. Arch Intern Med 157: 849–855.
42. Takeda A. Kunieda E. Sanuki N. Aoki Y. Oku Y. Handa H. (2012) Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer. Lung Cancer 77: 77–82.
43. Takeda A. Kunieda E. Sanuki N. Ohashi T. Oku Y. Sudo Y. (2009) Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple ARC therapy. Int J Radiat Oncol Biol Phys 74: 363–369.
44. Timmerman R. Paulus R. Galvin J. Michalski J. Straube W. Bradley J. (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303: 1070–1076.
45. Verstegen N. Lagerwaard F. Haasbeek C. Slotman B. Senan S. (2011) Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. Radiother Oncol 101: 250–254.
46. Videtic G. Stephans K. (2010) The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep 12: 235–241.
47. Wahidi M. Govert J. Goudar R. Gould M. McCrory D. and American College of Chest Physicians (2007) Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132: 94S–107S.